To include your compound in the COVID-19 Resource Center, submit it here.

Duodopa levodopa/carbidopa: Interim Phase III data

Interim data from 192 patients in an open-label, international Phase III trial showed that Duodopa significantly reduced daily "off" time

Read the full 203 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE